Dow Down0.22% Nasdaq Up0.14%

More On OPTR

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Optimer Pharmaceuticals, Inc. (OPTR)

-NasdaqGS
12.78 0.00(0.00%) Oct 23
|After Hours : 12.90 Up 0.12 (0.94%) 6:39PM EDT - Nasdaq Real Time Price
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.5
Mean Recommendation (last week):2.7
Change:-0.2

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:14.00
Median Target:14.00
High Target:16.00
Low Target:12.00
No. of Brokers:2

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
May 10, 2013NeedhamDowngradeBuyHold
May 10, 2013Robert W. BairdDowngradeOutperformNeutral
Feb 7, 2013Robert W. BairdInitiated Outperform
Oct 9, 2012Ladenburg ThalmannDowngradeBuyNeutral
Oct 9, 2012OppenheimerDowngradeOutperformPerform
Dec 1, 2010Robert W. BairdUpgradeNeutralOutperform
Nov 22, 2010JMP SecuritiesUpgradeMkt PerformMkt Outperform
Jan 22, 2010Ladenburg ThalmannUpgradeNeutralBuy
Nov 12, 2009OppenheimerUpgradePerformOutperform
Nov 4, 2009Ladenburg ThalmannDowngradeBuyNeutral

More Upgrades & Downgrades for OPTR

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0000
Buy0000
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.